Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
NCT ID: NCT05860790
Last Updated: 2023-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2023-03-10
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
NCT06290076
Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients
NCT04257305
Cerebral Venous Thrombosis Cohort Study in China Mainland
NCT03919305
Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.
NCT02814162
Thrombus Imaging and Treatment Analytics in Neurology
NCT05663281
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
This is a clinical prediction model that uses perioperative clinical indicators and laboratory tests to predict the occurrence of VTE after neurosurgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. underwent neurosurgical procedures during hospitalization
3. underwent preoperative ultrasound examination
Exclusion Criteria
2. a patient with venous thromboembolism within the past three months before surgery
3. a patient with anticoagulant therapy (direct oral anticoagulants, low molecular weight heparin) was administered continuously or intermittently before admission
4. a patient with a prior coagulation dysfunction
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hongwei Zhang
Vice President of Sanbo Brain Hospital, Capital Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongwei Zhang, Prof.
Role: PRINCIPAL_INVESTIGATOR
Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanbo Brain Hospital, Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Val. VTE pred. model post-op
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.